| Literature DB >> 36135574 |
Toqa Alabyadh1, Riyadh Albadri1, Ali Es-Haghi1, Mohammad Ehsan Taghavizadeh Yazdi2, Narges Ajalli3, Abbas Rahdar4, Vijay Kumar Thakur5,6,7,8.
Abstract
The Zinc-doped cerium oxide nanocomposite (ZnO/CeO2 NC) was synthesized using a metal-organic framework as a precursor through the combustion method. It was characterized by powder X-ray diffraction (PXRD), Fourier transform infrared spectroscopy (FTIR), field emission electron microscopy (FESEM), energy dispersive analysis (EDX), transmission electron microscopy (TEM), dynamic light scattering (DLS), and ξ-potential. The PXRD demonstrated the successful synthesis of ZnO/CeO2 NC with a crystallite size of 31.9 nm. FESEM and TEM images displayed hexagonal and spherical morphologies, and the solid-phase size was 65.03 ± 30.86 nm for ZnO/CeO2 NCs. DLS, TEM, and FESEM showed that the NCs have a high tendency for agglomeration/aggregation in both aqueous media and solid phase. The anticancer attributes of ZnO/CeO2 NC were investigated against Liver cancer cells (HepG2), which showed inhibition of cancer cell growth on a concentration-dependent gradient. The cell toxicity effects of ZnO/CeO2 nanocomposites were also studied toward NIH-3T3, in which the data displayed the lower toxicity of NC compared to the HepG2 cell line.Entities:
Keywords: anticancer; cerium oxide; doping; metal-organic framework; nanoceria; zinc oxide
Year: 2022 PMID: 36135574 PMCID: PMC9503907 DOI: 10.3390/jfb13030139
Source DB: PubMed Journal: J Funct Biomater ISSN: 2079-4983
Figure 1Pictorial diagram for synthetic procedure.
Figure 2The FTIR spectrum of the ZnO/CeO2 NCs.
Figure 3PXRD analyses of the CeO2 NPs and ZnO/CeO2 NCs.
Figure 4(a–c) FESEM images and (d) EDX analysis of the ZnO/CeO2 NCs.
Figure 5(a–c) FESEM images and (d) particle size distribution of the ZnO/CeO2 NCs.
Figure 6The hydrodynamic size dispersion of the ZnO/CeO2 NCs by intensity and number.
Figure 7Comparative diagram of cytotoxicity properties of fabricated (b) ZnO/CeO2, (d) ZnO, (f) CeO2 NCs against NIH-3T3 and cytotoxicity properties of (a) fabricated ZnO/CeO2, (c) ZnO, (e) CeO2 NCs against HepG2. The percentages were displayed relative to control cells. * p < 0.05, ** p < 0.01, *** p < 0.001 indicated significant difference as compared to the control.
Figure 8The cytotoxicity effect of doxorubicin against NIH-3T3 and HepG2. ** p < 0.01, *** p < 0.001 indicated significant difference as compared to the control.